U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H31ClN6O7
Molecular Weight 599.035
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Losartan N2 Glucuronide

SMILES

CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN(N=N4)[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O

InChI

InChIKey=NGFMQMUIOUSHGR-RTCYWULBSA-N
InChI=1S/C28H31ClN6O7/c1-2-3-8-20-30-25(29)19(14-36)34(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)26-31-33-35(32-26)27-23(39)21(37)22(38)24(42-27)28(40)41/h4-7,9-12,21-24,27,36-39H,2-3,8,13-14H2,1H3,(H,40,41)/t21-,22-,23+,24-,27+/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
Losartan N2 Glucuronide
Common Name English
(2S,3S,4S,5R,6R)-6-[5-[2-[4-[[2-butyl-4-chloro-5-(hydroxymethyl)imidazol-1-yl]methyl]phenyl]phenyl]tetrazol-2-yl]-3,4,5-trihydroxyoxane-2-carboxylicacid
Systematic Name English
L-158783
Common Name English
β-D-Glucopyranuronic acid, 1-[5-[4′-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-
Systematic Name English
(3S,4S,5S,6R)-6-{5-[2-(4-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}phenyl)phenyl]-2H-1,2,3,4-tetrazol-2-yl}-3,4,5-trihydroxyoxane-2-carboxylic acid
Systematic Name English
1-[5-[4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-β-D-glucopyranuronic acid
Systematic Name English
Losartan N2-β-D-glucuronide
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID70678715
Created by admin on Sat Dec 16 15:32:59 GMT 2023 , Edited by admin on Sat Dec 16 15:32:59 GMT 2023
PRIMARY
FDA UNII
BCN3CNE9GF
Created by admin on Sat Dec 16 15:32:59 GMT 2023 , Edited by admin on Sat Dec 16 15:32:59 GMT 2023
PRIMARY
PUBCHEM
49849772
Created by admin on Sat Dec 16 15:32:59 GMT 2023 , Edited by admin on Sat Dec 16 15:32:59 GMT 2023
PRIMARY
CAS
138584-35-7
Created by admin on Sat Dec 16 15:32:59 GMT 2023 , Edited by admin on Sat Dec 16 15:32:59 GMT 2023
PRIMARY